Kymera Therapeutics, Inc. Business Finance Contracts & Agreements
15 Contracts & Agreements
- Investor Rights Agreements (1 contract)
- Purchase Agreements (1)
- Registration Rights Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (4)
- Warrant Agreements (3)
- Form of Pre-Funded Warrant (Filed With SEC on August 20, 2024)
- Underwriting Agreement, dated August 19, 2024, by and among Kymera Therapeutics, Inc. and Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, TD Securities (USA) LLC and Stifel,... (Filed With SEC on August 20, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on January 5, 2024)
- Underwriting Agreement, dated January 4, 2024, by and among Kymera Therapeutics, Inc. and Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC (Filed With SEC on January 5, 2024)
- Registration Rights Agreement, dated August 18, 2022, by and among Kymera Therapeutics, Inc. and the persons party thereto (Filed With SEC on August 19, 2022)
- Securities Purchase Agreement, dated August 18, 2022, by and among Kymera Therapeutics, Inc. and the persons party thereto (Filed With SEC on August 19, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on August 19, 2022)
- Form of Underwriting Agreement (Filed With SEC on June 28, 2021)
- Amended and Restated 2020 Employee Stock Purchase Plan (Filed With SEC on November 5, 2020)
- Form of Common Stock Purchase Agreement between the Registrant and Vertex Pharmaceuticals Incorporated (Filed With SEC on August 17, 2020)
- 2020 Employee Stock Purchase Plan (Filed With SEC on August 17, 2020)
- Specimen Common Stock Certificate (Filed With SEC on August 17, 2020)
- Form of Underwriting Agreement (Filed With SEC on August 17, 2020)
- 2018 Stock Option and Grant Plan, and form of award agreements thereunder (Filed With SEC on July 31, 2020)
- Second Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, effective as of March 11, 2020 (Filed With SEC on July 31, 2020)
